The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TMB and BRAF mutation status are independent predictive factors in stage IIIC/D/IV melanoma patients receiving adjuvant PD-1 antibodies.
 
Andrea Forschner
Honoraria - Bristol-Myers Squibb; CeGaT; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Research Funding - Stiftung Immunonkologie BMS (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche
 
Julia Eckardt
Other Relationship - Novartis; Pierre Fabre
 
Peter Martus
Consulting or Advisory Role - Merck Serono
 
Sorin Armeanu-Ebinger
No Relationships to Disclose
 
Stephan Ossowski
No Relationships to Disclose
 
Irina Bonzheim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche
 
Thomas Eigentler
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Philogen; Roche
 
Teresa Maria Santos Amaral
Honoraria - Bristol-Myers Squibb; CeCaVa; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; CeCaVa; Novartis
Research Funding - NeraCare GmbH (Inst); Novartis (Inst); Sanofi (Inst); Skyline Diagnostics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Lukas Flatz
Patents, Royalties, Other Intellectual Property - Patent for LCMV based vaccine vectors
 
Claus Garbe
Honoraria - BMS; MSD Oncology; NeraCare GmbH; Novartis; Philogen; Roche/Genentech; Sanofi
Consulting or Advisory Role - BMS; MSD Oncology; NeraCare GmbH; Novartis; Philogen; Roche/Genentech; Sanofi
Research Funding - BMS; NeraCare GmbH; Novartis; Roche/Genentech
 
Christopher Schroeder
Research Funding - BMS; Illumina (Inst); Novartis (Inst)